Novavax to Participate in TD Cowen's 43rd Annual Health Care Conference

Rhea-AI Summary

Novavax (Nasdaq: NVAX), a leader in protein-based vaccines, announced its participation in the TD Cowen's 43rd Annual Health Care Conference on March 8, 2023, from 9:50 – 10:20 a.m. EST. The conference will take place at the Boston Marriott Copley Place. John Trizzino, Chief Commercial Officer, will represent the company during a fireside chat moderated by Georgi Yordanov, an Equity Research Analyst in Biotechnology. A replay of the session will be accessible on Novavax's website for 90 days post-conference.

GAITHERSBURG, Md., March 6, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that it will participate in TD Cowen's 43^rd Annual Health Care Conference.

Conference Details:
Fireside Chat
Date:		Wednesday, March 8, 2023
Time:		9:50 – 10:20 a.m. Eastern Standard Time (EST)
Location:		Boston Marriott Copley Place in Boston, Massachusetts
Moderator:		Georgi Yordanov, Equity Research Analyst – Biotechnology
Novavax participant:		John Trizzino, Chief Commercial Officer and Chief Business Officer
Conference
Event:		Investor Meetings
Date:		Wednesday, March 8, 2023

Recordings
A replay of the recorded fireside session will be available through the Events & presentations page of the Company's website at ir.novavax.com for 90 days from the date of the conference.

About Novavax
Novavax, Inc. (Nasdaq: NVAX) promotes improved health by discovering, developing and commercializing innovative vaccines to protect against serious infectious diseases. Novavax, a global company based in Gaithersburg, Md., U.S., offers a differentiated vaccine platform that combines a recombinant protein approach, innovative nanoparticle technology and Novavax's patented Matrix-M adjuvant to enhance the immune response. Focused on the world's most urgent health challenges, Novavax is currently evaluating vaccines for COVID-19, influenza, and COVID-19 and influenza combined. Please visit novavax.com and LinkedIn for more information.

CONTACTS

Investors
Erika Schultz
240-268-2022
ir@novavax.com

Media
Ali Chartan
240-720-7804
media@novavax.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-participate-in-td-cowens-43rd-annual-health-care-conference-301762705.html

SOURCE Novavax, Inc.

FAQ

When is Novavax participating in the TD Cowen Health Care Conference?

Novavax will participate on March 8, 2023, from 9:50 – 10:20 a.m. EST.

Who will represent Novavax at the TD Cowen Conference?

John Trizzino, Chief Commercial Officer, will represent Novavax.

Where is the TD Cowen Annual Health Care Conference held?

It is held at the Boston Marriott Copley Place in Boston, Massachusetts.

What can I expect from Novavax's participation in the conference?

Expect insights from the fireside chat moderated by Georgi Yordanov, focusing on Novavax's developments.

How can I access Novavax's conference session replay?

The replay will be available on Novavax's Events & Presentations page for 90 days.

What is the significance of Novavax's Matrix-M adjuvant?

It enhances the immune response in their protein-based vaccines.